Top Markets
Coin of the day
Nika Pharmaceuticals Inc. Nika Pharmaceuticals Inc.

Nika Pharmaceuticals Inc.

NIKA
Rank in Stocks #14185
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in... Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
Share Price
$0.41
Last synced: 2026-08-28
Market Cap
$429.91M
Change (1 day)
0.00%
Change (1 year)
-56.72%
Country
US
Trade Nika Pharmaceuticals Inc. (NIKA)

Category

Earnings for Nika Pharmaceuticals Inc. (NIKA)
Earnings in 2026 TTM: 0
According to Nika Pharmaceuticals Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Nika Pharmaceuticals Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors